ISIS has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
ISIS Pharmaceuticals Inc's account receivable for the three months ended in Jun. 2015 was $3.3 Mil. ISIS Pharmaceuticals Inc's revenue for the three months ended in Jun. 2015 was $120.4 Mil. Hence, ISIS Pharmaceuticals Inc's days sales outstanding for the three months ended in Jun. 2015 was 2.47.
ISIS Pharmaceuticals Inc's days sales outstanding declined from Jun. 2014 (67.05) to Jun. 2015 (2.47).
Days sales outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's accounts receivables are being managed.
Account receivable can be measured by Days Sales Outstanding.
ISIS Pharmaceuticals Inc's Days Sales Outstanding for the fiscal year that ended in Dec. 2014 is calculated as
ISIS Pharmaceuticals Inc's Days Sales Outstanding for the quarter that ended in Jun. 2015 is calculated as:
For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.
ISIS Pharmaceuticals Inc Annual Data
ISIS Pharmaceuticals Inc Quarterly Data